The Study of CM310 in Patients With Atopic Dermatitis

NCT04893707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Atopic Dermatitis

Interventions

BIOLOGICAL: CM310

Sponsor

Keymed Biosciences Co.Ltd